ClinicalTrials.Veeva

Menu

Prevalence of OSA in Patients of ILD

A

Assiut University

Status

Not yet enrolling

Conditions

OSA

Study type

Observational

Funder types

Other

Identifiers

NCT06058052
ILD,OSA

Details and patient eligibility

About

To evaluate the clinical predictors of OSA in patients with ILD

Full description

Interstitial lung diseases (ILDs) are a group of heterogeneous disorders characterized by varying degrees of fibrosis and inflammation of lung parenchyma.

Obstructive sleep apnea is a type of sleep disordered breathing characterized by repeated episodes of apnea and hypopnea during sleep due to narrowing or occlusion of the upper airway.

It was found that the prevalence of OSA is as high as 80% among patients with idiopathic pulmonary fibrosis (IPF). Despite this common association, there is limited research in this field. There is great need for further studies to highlight this association and understand the underlying pathophysiological mechanisms implicated in those patients, to ultimately guide the appropriate management.

Enrollment

81 estimated patients

Sex

All

Ages

18 to 65 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Patients presented to Chest Department with interstitial lung disease will be included, screened for OSA.

Exclusion criteria

  • Age: less than 18 years. Unstable patients or need for ICU admission

Trial contacts and locations

0

Loading...

Central trial contact

Mohamed Khalaf, MD; Hend saleh, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems